NYC startupfromWIRED3 months agoTrump's FDA Cuts Are Putting Drug Development at RiskStaffing cuts at the FDA may hinder the timely development and approval of new drugs.
Artificial intelligencefromWIRED1 month agoOpenAI and the FDA Are Holding Talks About Using AI In Drug EvaluationFDA is exploring AI technologies to expedite drug approval processes.AI-assisted reviews could potentially modernize the drug approval timeline.
Artificial intelligencefromFuturism1 week agoThe FDA Is Already Outsourcing Drug and Food Analysis to Error-Plagued AI ChatbotFDA is integrating AI to enhance the efficiency of drug reviews and applications.
Artificial intelligencefromFast Company2 weeks agoThis new AI tool at the Food and Drug Administration promises to speed up scientific reviewsThe FDA has launched Elsa, a generative AI tool, to enhance operational efficiency and scientific reviews.
NYC startupfromWIRED3 months agoTrump's FDA Cuts Are Putting Drug Development at RiskStaffing cuts at the FDA may hinder the timely development and approval of new drugs.
Artificial intelligencefromWIRED1 month agoOpenAI and the FDA Are Holding Talks About Using AI In Drug EvaluationFDA is exploring AI technologies to expedite drug approval processes.AI-assisted reviews could potentially modernize the drug approval timeline.
Artificial intelligencefromFuturism1 week agoThe FDA Is Already Outsourcing Drug and Food Analysis to Error-Plagued AI ChatbotFDA is integrating AI to enhance the efficiency of drug reviews and applications.
Artificial intelligencefromFast Company2 weeks agoThis new AI tool at the Food and Drug Administration promises to speed up scientific reviewsThe FDA has launched Elsa, a generative AI tool, to enhance operational efficiency and scientific reviews.
Intellectual property lawfromIPWatchdog.com | Patents & Intellectual Property Law1 month agoFederal Circuit Reverses Injunction Against Avadel Due to Hatch-Waxman Safe HarborFederal Circuit overturned injunction, allowing Avadel to conduct pre-approval activities for Lumryz under Hatch-Waxman 'safe harbor'.
Artificial intelligencefromNature2 months agoThe future of Alzheimer's treatmentRecent approvals of anti-amyloid drugs provide hope in Alzheimer's treatment, although their modest effectiveness remains a topic of debate.
Alternative medicinefromwww.bournemouthecho.co.uk3 months agoNHS approves new pill that will 'transform' the treatment of endometriosisA new combination drug, Ryeqo, offers effective treatment for endometriosis with convenience and affordability for patients.